Pectoral Nerve Blocks (PECs) for Cardiovascular Implantable Electronic Device Placement
Status:
Not yet recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether administration of a pectoral nerve blocks
(Pecs I and II) with 0.25% bupivacaine are more effective as compared to placebo to provide
analgesia for cardiac implantable electronic device (CIED) placement in cardiac
electrophysiology lab